Literature DB >> 35465340

Temporary positive expiratory pressure (TPEP) as an alternative approach in the treatment of persistent atelectasis in a patient with Steinert disease: a case report.

Antonietta Coppola1, Anna Annunziata1, Elena Sciarrillo1, Salvatore Musella1, Giuseppe Fiorentino1.   

Abstract

We describe the clinical case of a patient affected by Steinert disease with persistent dyspnea complicated by a complete obstructive atelectasis of left lower lung lobe. The atelectasis has been successfully treated using the TPEP machine, with resolution of radiological pattern and improvement of the symptoms. ©2022 Gaetano Conte Academy - Mediterranean Society of Myology.

Entities:  

Mesh：

Year:  2022        PMID： 35465340      PMCID： PMC9004332          DOI： 10.36185/2532-1900-069

Source DB:  PubMed          Journal:  Acta Myol        ISSN： 1128-2460


  6 in total

1.  Active lung volume recruitment to preserve vital capacity in Duchenne muscular dystrophy.

Authors:  Michael Chiou; John R Bach; Lavina Jethani; Michael F Gallagher
Journal:  J Rehabil Med       Date:  2017-01-19       Impact factor: 2.912

2.  The importance of proximal and distal air bronchograms in the management of atelectasis.

Authors:  R S Harris
Journal:  J Can Assoc Radiol       Date:  1985-06

3.  Short-term effects of three slow expiratory airway clearance techniques in patients with bronchiectasis: a randomised crossover trial.

Authors:  B Herrero-Cortina; J Vilaró; D Martí; A Torres; M San Miguel-Pagola; V Alcaraz; E Polverino
Journal:  Physiotherapy       Date:  2015-12-01       Impact factor: 3.358

4.  Comparison of intermittent positive pressure breathing and temporary positive expiratory pressure in patients with severe chronic obstructive pulmonary disease.

Authors:  Antonello Nicolini; Elena Mollar; Bruna Grecchi; Norma Landucci
Journal:  Arch Bronconeumol       Date:  2013-12-08       Impact factor: 4.872

5.  Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial.

Authors:  Elena Venturelli; Ernesto Crisafulli; Assunta DeBiase; Daniela Righi; Daniele Berrighi; Pier Paolo Cavicchioli; Guido Vagheggini; Francesco Dabrosca; Bruno Balbi; Mara Paneroni; Luca Bianchi; Michele Vitacca; Vittoria Galimberti; Michele Zaurino; Giorgio Schiavoni; Andrea Iattoni; Nicolino Ambrosino; Enrico M Clini
Journal:  Clin Rehabil       Date:  2012-09-11       Impact factor: 3.477
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.